71-Year-Old with Triple Vessel ACS: CABG vs. Angiogram/PCI

Clinical Context

Step 1 — Angiography is ALWAYS the First Step

• Number and location of lesions
• Severity (% stenosis, TIMI flow)
• Suitability for PCI vs. CABG (lesion morphology, calcification, CTO, tortuosity)
• Left ventricular function (EF)
• SYNTAX score — the key anatomic complexity score that guides PCI vs. CABG

Step 2 — Decision Framework After Angiography

Class I Indications Favoring CABG in 3VD ACS

"CABG favored for patients with preserved exercise capacity, multivessel CAD, lower LVEF, three-vessel disease and higher LV end-systolic volume index, diabetic patients with LV dysfunction." — Fuster and Hurst's The Heart, 15th Ed.

"Surgical coronary revascularization is more effective than medical therapy alone in hemodynamically significant multivessel disease, impaired LV function, ventricular enlargement, moderate or severe mitral regurgitation." — Fuster & Hurst's The Heart, 15th Ed.

When PCI is Preferred in 3VD ACS

Harrison's (2025): "PCI is preferred over surgical therapy in most high-risk ACS patients unless they have severe multivessel disease or the culprit lesion cannot be adequately determined or treated."

Step 3 — Specific Considerations for Age 71

Age is a Double-Edged Factor:

• Operative mortality for CABG increases with age (EuroSCORE II accounts for this)
• Stroke risk ~1–3% (higher in elderly)
• Longer recovery, frailty risk, cognitive effects of cardiopulmonary bypass
• SWEDEHEART registry (2025, n=57,097 NSTEMI patients): CABG survival benefit diminishes with shorter life expectancy and is most pronounced in patients <70 years of age [PMID: 39601339]

• In a non-frail 71-year-old with 3VD + good anatomy + preserved function: CABG still provides superior long-term survival
• Complete revascularization is more reliably achieved with CABG
• Lower repeat revascularization rates (PCI: 3× higher repeat procedures, SWEDEHEART 2025)

Step 4 — Complete vs. Culprit-Only Revascularization (Key Evidence)

Recommended Approach: The Heart Team Model

"It is optimal to have a discussion among the cardiac surgeon, interventional cardiologist, and the physicians caring for the patient (Heart Team) to weigh the choices properly." — Harrison's 2025

Practical Algorithm for This Patient

71-year-old + Triple ACS
         ↓
1. URGENT CORONARY ANGIOGRAPHY (always first)
         ↓
2. Assess: SYNTAX score | EF | Lesion anatomy | Comorbidities | Frailty
         ↓
    ┌────────────────────────────────────┐
    │ SYNTAX ≥33 OR LM OR DM + LV dysfn │ → CABG (if surgically fit)
    │ SYNTAX ≤22, no DM, good anatomy   │ → PCI (complete revascularization)
    │ SYNTAX 23–32 (intermediate)       │ → Heart Team decision
    └────────────────────────────────────┘
         ↓
3. STEMI: Primary PCI of culprit NOW → staged non-culprit later
   NSTEMI/UA: Early invasive (PCI) or CABG per Heart Team

Key Takeaways

1. Angiography is not the alternative — it is step 1. You cannot choose CABG vs. PCI without it.
2. 3VD in ACS strongly favors CABG when anatomy is complex (SYNTAX ≥33), EF is reduced, or diabetes is present — even at age 71 if the patient is non-frail.
3. At age 71, surgical risk is elevated but not prohibitive. CABG still offers survival advantage over 7–10 years in suitable patients.
4. If PCI is chosen, complete (not culprit-only) revascularization is the goal — proven to reduce all-cause mortality (JACC 2024 meta-analysis).
5. Heart Team approach is mandatory in 3VD — cardiologist + cardiac surgeon + clinical team.

• Harrison's Principles of Internal Medicine, 22nd Ed. (2025) — Ch. 287
• Fuster and Hurst's The Heart, 15th Ed. — Ch. 47
• Reddy et al., JACC 2024 — PMID 38986670
• Faro et al., JACC Cardiovasc Interv 2023 — PMID 37821180
• Omerovic et al. (SWEDEHEART), Eur Heart J 2025 — PMID 39601339